Pregnane X receptor (PXR) is the major regulator of xenobiotic metabolism. PXR itself is controlled by various signaling molecules including glucocorticoids. Moreover, negative feed-back regulation has been proposed at the transcriptional level. We examined the involvement of the 3'-untranslated region (3'-UTR) of NR1I2 mRNA and microRNAs in PXR- and glucocorticoid receptor (GR)-mediated regulation of NR1I2 gene expression. PXR ligands were found to significantly downregulate NR1I2 mRNA expression in a set of 14 human hepatocyte cultures. Similarly, PXR was downregulated by PCN in the C57/BL6 mice liver. In mechanistic studies with the full-length 3'-UTR cloned into luciferase reporter or expression vectors, we showed that the 3'-UTR reduces PXR expression. From the miRNAs tested, miR-18a-5p inhibited both NR1I2 expression and CYP3A4 gene induction. Importantly, we observed significant upregulation of miR-18a-5p expression 6 h after treatment with the PXR ligand rifampicin, which indicates a putative mechanism underlying NR1I2 negative feed-back regulation in hepatic cells. Additionally, glucocorticoids upregulated NR1I2 expression not only through the promoter region but also via 3'-UTR regulation, which likely involves downregulation of miR-18a-5p. We conclude that miR-18a-5p is involved in the down-regulation of NR1I2 expression by its ligands and in the upregulation of NR1I2 mRNA expression by glucocorticoids in hepatic cells.

Department of Pharmacology and Toxicology Faculty of Pharmacy in Hradec Kralove Charles University Hradec Kralove CZ 500 05 Czech Republic

Department of Pharmacology Faculty of Medicine in Hradec Kralove Charles University Hradec Kralove CZ 500 03 Czech Republic

Institute of Clinical Biochemistry and Diagnostics University Hospital Hradec Kralove Hradec Kralove CZ 500 05 Czech Republic

IRMB INSERM University Montpellier Montpellier France

Zobrazit více v PubMed

Oladimeji P.O., Chen T. PXR: more than just a master xenobiotic receptor. Mol Pharmacol. 2018;93:119–127. PubMed PMC

Yan J., Xie W. A brief history of the discovery of PXR and CAR as xenobiotic receptors. Acta Pharm Sin B. 2016;6:450–452. PubMed PMC

Wu B., Li S., Dong D. 3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR. Drug Discov Today. 2013;18:574–581. PubMed

Hyrsova L., Smutny T., Carazo A., Moravcik S., Mandikova J., Trejtnar F. The pregnane X receptor down-regulates organic cation transporter 1 (SLC22A1) in human hepatocytes by competing for (“squelching”) SRC-1 coactivator. Br J Pharmacol. 2016;173:1703–1715. PubMed PMC

Pavek P. Pregnane X receptor (PXR)-mediated gene repression and cross-talk of PXR with other nuclear receptors via coactivator interactions. Front Pharmacol. 2016;7:456. PubMed PMC

Smutny T., Mani S., Pavek P. Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily. Curr Drug Metabol. 2013;14:1059–1069. PubMed PMC

Gibson G.G., Phillips A., Aouabdi S., Plant K., Plant N. Transcriptional regulation of the human pregnane-X receptor. Drug Metab Rev. 2006;38:31–49. PubMed

Lamba V., Ghodke Y., Guan W., Tracy T.S. Microrna-34a is associated with expression of key hepatic transcription factors and cytochromes P450. Biochem Biophys Res Commun. 2014;445:404–411. PubMed PMC

Aouabdi S., Gibson G., Plant N. Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR. Drug Metab Dispos. 2006;34:138–144. PubMed

Pascussi J.M., Drocourt L., Gerbal-Chaloin S., Fabre J.M., Maurel P., Vilarem M.J. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur J Biochem. 2001;268:6346–6358. PubMed

Pascussi J.M., Drocourt L., Fabre J.M., Maurel P., Vilarem M.J. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol. 2000;58:361–372. PubMed

Iwazaki N., Kobayashi K., Morimoto K., Hirano M., Kawashima S., Furihata T. Involvement of hepatocyte nuclear factor 4 alpha in transcriptional regulation of the human pregnane X receptor gene in the human liver. Drug Metab Pharmacokinet. 2008;23:59–66. PubMed

Takagi S., Nakajima M., Mohri T., Yokoi T. Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem. 2008;283:9674–9680. PubMed

Cai Y., Yu X., Hu S., Yu J. A brief review on the mechanisms of miRNA regulation. Genom Proteom Bioinform. 2009;7:147–154. PubMed PMC

Kozomara A., Griffiths-Jones S. Mirbase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68–D73. PubMed PMC

O'Brien J., Hayder H., Zayed Y., Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 2018;9:402. PubMed PMC

Nakano M., Nakajima M. Current knowledge of microrna-mediated regulation of drug metabolism in humans. Expert Opin Drug Metabol Toxicol. 2018;14:493–504. PubMed

Yu A.M., Pang Y.Z. Noncoding micrornas: small RNAs play a big rolein regulation of ADME?. Acta Pharm Sin B. 2009;2:93–101. PubMed PMC

Yu A.M., Tian Y., Tu M.J., Ho P.Y., Jilek J.L. Microrna pharmacoepigenetics: posttranscriptional regulation mechanisms behind variable drug disposition and strategy to develop more effective therapy. Drug Metab Dispos. 2016;44:308–319. PubMed PMC

Sharma D., Turkistani A.A., Chang W., Hu C., Xu Z., Chang T.K.H. Negative regulation of human pregnane X receptor by microrna-18a-5p: evidence for suppression of microrna-18a-5p expression by rifampin and rilpivirine. Mol Pharmacol. 2017;92:48–56. PubMed

Vachirayonstien T., Yan B. Microrna-30c-1-3p is a silencer of the pregnane X receptor by targeting the 3ʹ-untranslated region and alters the expression of its target gene cytochrome p450 3A4. Biochim Biophys Acta. 2016;1859:1238–1244. PubMed PMC

Ramamoorthy A., Li L., Gaedigk A., Bradford L.D., Benson E.A., Flockhart D.A. In silico and in vitro identification of micrornas that regulate hepatic nuclear factor 4alpha expression. Drug Metab Dispos. 2012;40:726–733. PubMed PMC

Li J., Zhao J., Wang H., Li X., Liu A., Qin Q. Microrna-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor. OncoTargets Ther. 2018;11:5885–5894. PubMed PMC

Bagamasbad P., Denver R.J. Mechanisms and significance of nuclear receptor auto- and cross-regulation. Gen Comp Endocrinol. 2011;170:3–17. PubMed PMC

Lin W., Wang Y.M., Chai S.C., Lv L., Zheng J., Wu J. SPA70 is a potent antagonist of human pregnane X receptor. Nat Commun. 2017;8:741. PubMed PMC

Doricakova A., Novotna A., Vrzal R., Pavek P., Dvorak Z. The role of residues t248, y249 and t422 in the function of human pregnane X receptor. Arch Toxicol. 2013;87:291–301. PubMed

Pichard L., Raulet E., Fabre G., Ferrini J.B., Ourlin J.C., Maurel P. Human hepatocyte culture. Methods Mol Biol. 2006;320:283–293. PubMed

Isom H.C., Secott T., Georgoff I., Woodworth C., Mummaw J. Maintenance of differentiated rat hepatocytes in primary culture. Proc Natl Acad Sci USA. 1985;82:3252–3256. PubMed PMC

Smutny T., Bitman M., Urban M., Dubecka M., Vrzal R., Dvorak Z. U0126, a mitogen-activated protein kinase kinase 1 and 2 (MER1 and 2) inhibitor, selectively up-regulates main isoforms of CAP3A subfamily via a pregnane X receptor (PXR) in HerG2 cells. Arch Toxicol. 2014;88:2243–2259. PubMed

Dusek J., Carazo A., Trejtnar F., Hyrsova L., Holas O., Smutny T. Steviol, an aglycone of steviol glycoside sweeteners, interacts with the pregnane X (PXR) and aryl hydrocarbon (AHR) receptors in detoxification regulation. Food Chem Toxicol. 2017;109:130–142. PubMed

Campos-Melo D., Droppelmann C.A., Volkening K., Strong M.J. Comprehensive luciferase-based reporter gene assay reveals previously masked up-regulatory effects of miRNAs. Int J Mol Sci. 2014;15:15592–15602. PubMed PMC

Prasnicka A., Cermanova J., Hroch M., Dolezelova E., Rozkydalova L., Smutny T. Iron depletion induces hepatic secretion of biliary lipids and glutathione in rats. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862:1469–1480. PubMed

Smutny T., Tebbens J.D., Pavek P. Bioinformatic analysis of miRNAs targeting the key nuclear receptors regulating CYP3A4 gene expression: the challenge of the CYP3A4 “missing heritability” enigma. J Appl Biomed. 2015;13:181–188.

Zeng L., Chen Y., Wang Y., Yu L.R., Knox B., Chen J. MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation. Biochem Pharmacol. 2017;140:139–149. PubMed PMC

Bailey I., Gibson G.G., Plant K., Graham M., Plant N. A PXR-mediated negative feedback loop attenuates the expression of CYP3A in response to the PXR agonist pregnenalone-16alpha-carbonitrile. PLoS One. 2011;6 PubMed PMC

Kim S.W., Md H., Cho M., Kim N.H., Choi H.Y., Han J.W. Role of 14-3-3 sigma in over-expression of p-gp by rifampin and paclitaxel stimulation through interaction with PXR. Cell Signal. 2017;31:124–134. PubMed

Berthier A., Oger F., Gheeraert C., Boulahtouf A., Le Guevel R., Balaguer P. The novel antibacterial compound walrycin a induces human PXR transcriptional activity. Toxicol Sci. 2012;127:225–235. PubMed PMC

Ayed-Boussema I., Pascussi J.M., Zaied C., Maurel P., Bacha H., Hassen W. Ochratoxin a induces CYP3A4, 2B6, 3A5, 2C9, 1A1, and CYP1A2 gene expression in primary cultured human hepatocytes: a possible activation of nuclear receptors. Drug Chem Toxicol. 2012;35:71–80. PubMed

Maglich J.M., Stoltz C.M., Goodwin B., Hawkins-Brown D., Moore J.T., Kliewer S.A. Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol. 2002;62:638–646. PubMed

Gerets H.H., Tilmant K., Gerin B., Chanteux H., Depelchin B.O., Dhalluin S. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol. 2012;28:69–87. PubMed PMC

Wei Z.Y., Chen M.J., Zhang Y.T., Wang X.F., Jiang S.S., Wang Y. No correlation of hsa-miR-148a with expression of PXR or CYP3A4 in human livers from Chinese han population. PLoS One. 2013;8 PubMed PMC

Rieger J.K., Klein K., Winter S., Zanger U.M. Expression variability of absorption, distribution, metabolism, excretion-related micrornas in human liver: influence of nongenetic factors and association with gene expression. Drug Metab Dispos. 2013;41:1752–1762. PubMed

Takahashi K., Tatsumi N., Fukami T., Yokoi T., Nakajima M. Integrated analysis of rifampicin-induced microrna and gene expression changes in human hepatocytes. Drug Metab Pharmacokinet. 2014;29:333–340. PubMed

Ramamoorthy A., Liu Y., Philips S., Desta Z., Lin H., Goswami C. Regulation of microRNA expression by rifampin in human hepatocytes. Drug Metab Dispos. 2013;41:1763–1768. PubMed PMC

Wang Z., Burke P.A. The role of micrornas in hepatocyte nuclear factor-4alpha expression and transactivation. Biochim Biophys Acta. 2013;1829:436–442. PubMed PMC

Mogilyansky E., Rigoutsos I. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013;20:1603–1614. PubMed PMC

Smith L.K., Shah R.R., Cidlowski J.A. Glucocorticoids modulate microrna expression and processing during lymphocyte apoptosis. J Biol Chem. 2010;285:36698–36708. PubMed PMC

Expression dynamics of pregnane X receptor-controlled genes in 3D primary human hepatocyte spheroids

Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism